Molecular diagnostic tests for skin cancer patients that provide tumor-specific, actionable information to guide whether drug therapy is necessary or whether favorable survival estimates allow avoiding toxic treatment. Partners with pharmaceutical companies and clinical investigators to design trials that expand access to therapies for early-stage patients.